European Archives - Page 725 of 997 - European Medical Journal

Nanoparticles as Emerging Diagnostic Tools in Liquid Tumours

Nanotechnology has become an important approach to improving the diagnosis and treatment of cancer; advances in this area have made it possible to use…

Automated Item Generation: The Future of Medical Education Assessment?

A major innovation in psychometric science, termed automated item generation (AIG), holds the potential to revolutionise assessment in medical education.

New Test Can Predict the Rate of Racemisation in Drugs

HE RISK of a drug undergoing racemisation can be tested using a mathematical model developed by researchers from Cardiff University, Liverpool John…

New Research Shows How Alcohol Can Increase the Risk of Cancer

ALCOHOL can cause permanent genetic damage, helping explain the association between drinking and the risk of developing cancer, according to…

Delivering Healthcare to Modern Conflict Zones

The nature of recent conflicts around the world has brought about new challenges for the provision of healthcare.

Drinking Coffee Could Help Diagnose Parkinson’s Disease

PARKINSON’S disease patients may process caffeine differently, causing them to have lower caffeine levels in their blood after drinking tea and coffee…

New Antibiotic Developed for Gonorrhoea Treatment

SCIENTISTS at the University of York, UK have identified carbon monoxide-releasing molecules (CO-RMs) as an antimicrobial substance that can be developed…

Virus Injection May Help to Treat Aggressive Brain Cancer

AGGRESSIVE brain tumours could be treated by a virus being injected directly into the bloodstream, according to scientists from the University of Leeds…

Guidelines Updated to Support Routine Use of Endobronchial Valves in Severe Emphysema Patients

The UK National Institute for Health and Care Excellence (NICE) guidelines have been updated to support the routine use of endobronchial valves to treat…

FDA Designation Given to Combination Treatment in Pre-Menopausal Women with Advanced Breast Cancer

FDA Breakthrough Therapy designation has been given for a combination therapy used as an initial treatment for pre-menopausal women with HR+/HER2-…